Med. Pro Praxi 2007; 4(7): 326-328 [Neurol. pro Praxi, 2007; 1: 32-34]

Roztroušená skleróza a mateřství

MUDr. Dana Horáková
Centrum pro demyelinizační onemocnění Neurologická klinika 1. LF UK a VFN Praha

Roztroušená skleróza (RS) mozkomíšní je chronické onemocnění centrálního nervového systému postihující především mladé pacienty, častěji ženy v reprodukčním věku, které zvažují těhotenství. Data z kontrolovaných studií ukazují stabilizaci nemoci během gravidity, zvýšené riziko atak je během prvních 6 měsíců po porodu. V tomto období je vhodné zajištění preventivní medikací (optimálně intravenozními imunoglobuliny, které umoňují kojení). Vlastní porod může být veden fyziologickou cestou, není námitek proti epidurální anestezii. Většina medikamentů užívaných pro léčbu RS by měla být vysazena před plánovaným početím a nebo nejpozději v době zjištěné gravidity. Nejsou důkazy o tom, že by těhotenství z dlouhodobého hlediska negativně ovlivnovalo průběh RS.

Keywords: roztroušená skleróza, ataka, gravidita, mateřství, porod, kojení, intravenozní imunoglobuliny, kortikoidy

Published: October 20, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horáková D. Roztroušená skleróza a mateřství. Med. praxi. 2007;4(7):326-328.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, Achiron R. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 251: 1133-1137, 2004. Go to original source... Go to PubMed...
    2. Al-Shammri S, Rawoot P, Azizieh F, AbuQoora A, Hanna M, Saminathan TR, Raghupathy R: Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci 222: 21-27, 2004. Go to original source... Go to PubMed...
    3. Boskovic R, Wide R, Wolpin J, Bauer DJ, Koren G. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 65: 807-811, 2005. Go to original source... Go to PubMed...
    4. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339: 285-291, 1998. Go to original source... Go to PubMed...
    5. Damek DM, Shuster EA. Pregnancy and multiple sclerosis. Mayo Clin Proc 72: 977-989, 1997. Go to original source... Go to PubMed...
    6. de Seze J, Chapelotte M, Delalande S, Ferriby D, Stojkovic T, Vermersch P. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler 10: 596-597, 2004. Go to original source... Go to PubMed...
    7. Haas J. High dose IVIG in the post partum period for prevention of exacerbations in MS. Mult Scler 6 Suppl 2: S18-20; discussion S33, 2000. Go to original source... Go to PubMed...
    8. Lopez C, Comabella M, Tintore M, Sastre-Garriga J, Montalban X. Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients. Mult Scler 12: 421-427, 2006. Go to original source... Go to PubMed...
    9. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127, 2001. Go to original source... Go to PubMed...
    10. Millar JH, Allison RS, Cheeseman EA, Merrett JD. Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 82: 417-426, 1959. Go to original source... Go to PubMed...
    11. Orvieto R, Achiron A, Ben-Rafael Z, Achiron R. Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies. Fertil Steril 56: 1013-1020, 1991. Go to original source... Go to PubMed...
    12. Roullet E, Verdier-Taillefer MH, Amarenco P, Gharbi G, Alperovitch A, Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry 56: 1062-1065, 1993. Go to original source... Go to PubMed...
    13. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118 (Pt 1): 253-261, 1995. Go to original source... Go to PubMed...
    14. Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, Chang P, Francis GS. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 65: 802-806, 2005. Go to original source... Go to PubMed...
    15. Schapira K, Poskanzer DC, Newell DJ, Miller H. Marriage, pregnancy and multiple sclerosis. Brain 89: 419-428, 1966. Go to original source... Go to PubMed...
    16. Stenager E, Stenager EN, Jensen K. Effect of pregnancy on the prognosis for multiple sclerosis. A 5-year follow up investigation. Acta Neurol Scand 90: 305-308, 1994. Go to original source... Go to PubMed...
    17. Tillman AJ. The effect of pregnancy on multiple sclerosis and its management. Res Publ Assoc Res Nerv Ment Dis 28: 548-582, 1950.
    18. Verdru P, Theys P, D'Hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg 96: 38-41, 1994. Go to original source... Go to PubMed...
    19. Villard-Mackintosh L, Vessey MP. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47: 161-168, 1993. Go to original source... Go to PubMed...
    20. Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P, Confavreux C, The Pregnancy In Multiple Sclerosis G. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127: 1353-1360, 2004. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.